Integrichain Blog

Blog

Prescription Drug Fee
Contracts & Pricing Nick Lynch
March 13, 2025

Considerations for Branded Prescription Drug Fees

2 Minute Read

Keep up-to-date on Branded Prescription Drug Fees with this summary of critical insights from Nick Lynch, Partner at IntegriChain, covering key deadlines and factors.

Pharma (1)

Market Access Reena Patel
March 11, 2025

Navigating Market Access Challenges: Insights from Industry Leaders

3 Minute Read

The pharmaceutical industry is facing unprecedented challenges as market access dynamics continue to evolve. To navigate these complexities, companies must rethink channel, pricing, contracting, and patient access strategies.

Navigating Fair Market Value

Contracts & Pricing Nick Lynch
March 4, 2025

Navigating Fair Market Value and Bona Fide Service Fees in 2024/2025:...

4 Minute Read

In this blog, we recap the key insights shared by Nick Lynch, Partner at IntegriChain, and Suriya Janarthanan, Associate Director at Novartis, on how manufacturers can navigate FMV and...

pharma data strategy with AI/ML

Contracts & Pricing Jeff Uccello
February 28, 2025

Build a Next-Generation Commercial Data Strategy with AI & ML

2 Minute Read

In today’s rapidly evolving pharmaceutical landscape, creating an effective commercial data strategy is critical for achieving success.

new pharmaceutical government pricing tools

Government Pricing Carina Wang Jonathan Brier
January 24, 2025

Emerging Tools & Challenges in Pharmaceutical Government Pricing

2 Minute Read

The pharmaceutical industry faces increasing difficulty accurately calculating and reporting government prices due to stringent regulations and recent complex changes.

Data Centric

Market Access Blogs Rick Dutt Ankith Pokkuluri Manli Gomari
December 31, 2024

The Future of 340B and Independent Pharmacies in a Post-IRA World

4 Minute Read

Independent pharmacies are struggling due to the Inflation Reduction Act (IRA), which increases drug costs and tightens payer restrictions, affecting their finances. The 340B program, meant to aid low-income...

Gross to Net Automated Systems

Gross-to-Net Mathew Gravesande
December 28, 2024

Pharma Inventory Roll Forward Monitoring & Management

2 Minute Read

Efficient inventory management is crucial for healthcare organizations to ensure patient satisfaction, maintain financial stability, and mitigate supply chain risks. Moving forward, drug manufacturers must adapt their inventory management...

DSCSA Requirements with Compliance Solutions & Software

Contracts & Pricing Jeff Uccello Aaron Light Anthony Del Signore
December 20, 2024

Navigating DSCSA Requirements with Compliance Solutions & Software

4 Minute Read

As the industry approaches full compliance with DSCSA requirements, new challenges emerge, particularly in managing data discrepancies, addressing inventory exceptions, and navigating gross-to-net impacts.

Pharmaceutical team discussing the future of the pharmaceutical industry

Corporate Tim Murdoch
November 4, 2024

Why I Chose IntegriChain: A Journey from Tech Giants to Transforming...

2 Minute Read

Read the latest blog from our CCO Tim Murdoch, Why I Chose IntegriChain: A Journey from Tech Giants to Transforming Pharma Commercialization.

Medicare Part D Changes

Contracts & Pricing Ben Fanelli Michael Gorokhovsky
October 31, 2024

Industry Shifts: A Closer Look at Recent CMS and J&J Announcements

3 Minute Read

Read the latest on the CMS September Final Rule Overview & a Controversial 340B Rebate Policy

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article